Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| 10-K | 10-K | 10-K | 10-K |
Revenues: |
UNITED STATES | 347.8 | 202.0 | 138.3 | |
Non-US | 33.2 | 16.3 | 3.1 | 0.1 |
Other | | | | 80.1 |
Total revenues | 381.1 | 218.3 | 141.4 | 80.2 |
Revenue growth [+] | 74.5% | 54.4% | 76.3% | |
UNITED STATES | 72.2% | 46.1% | | |
Non-US | 103.7% | 420.2% | 3034.0% | |
Cost of goods sold | 233.5 | 161.2 | 108.1 | 65.5 |
Gross profit | 147.6 | 57.1 | 33.3 | 14.7 |
Gross margin | 38.7% | 26.2% | 23.5% | 18.4% |
Selling, general and administrative [+] | 83.2 | 39.4 | 22.6 | 14.6 |
Sales and marketing | 83.2 | 39.4 | 22.6 | 14.6 |
Other operating expenses | 142.2 | 81.8 | 43.7 | -36.5 |
EBITDA [+] | -70.1 | -60.5 | -29.8 | 38.5 |
EBITDA growth | 15.9% | 102.7% | -177.5% | |
EBITDA margin | -18.4% | -27.7% | -21.1% | 48.0% |
Depreciation | 4.4 | 3.1 | 2.3 | 1.5 |
EBITA | -74.5 | -63.6 | -32.1 | 37.0 |
EBITA margin | -19.5% | -29.1% | -22.7% | 46.1% |
Amortization of intangibles | 3.4 | 0.5 | 0.8 | 0.3 |
EBIT [+] | -77.9 | -64.1 | -33.0 | 36.7 |
EBIT growth | 21.6% | 94.4% | -189.9% | |
EBIT margin | -20.4% | -29.3% | -23.3% | 45.7% |
Non-recurring items [+] | | | | 1.7 |
Asset impairment | | | | 1.7 |
Interest expense | 4.4 | 0.9 | 1.1 | 0.2 |
Other income (expense), net | 6.3 | 3.5 | 3.0 | -34.7 |
Pre-tax income | -76.0 | -61.4 | -31.1 | 0.0 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | | 0.0% | 0.0% | |
Net income | -76.0 | -61.4 | -31.1 | 0.0 |
Net margin | -20.0% | -28.1% | -22.0% | 0.0% |
|
Basic EPS [+] | ($1.61) | ($2.33) | ($4.15) | $0.00 |
Growth | -30.9% | -43.8% | | |
Diluted EPS [+] | ($1.61) | ($2.33) | ($4.15) | $0.00 |
Growth | -30.9% | -43.8% | | |
|
Shares outstanding (basic) [+] | 47.2 | 26.3 | 7.5 | 6.3 |
Growth | 79.2% | 251.2% | 18.1% | |
Shares outstanding (diluted) [+] | 47.2 | 26.3 | 7.5 | 6.3 |
Growth | 79.2% | 251.2% | 18.1% | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|